medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2010, Number 07

<< Back Next >>

Ginecol Obstet Mex 2010; 78 (07)

Ultrastructural aspects of the HIV-1 infection in human placental villi with zidovudine treatment

Castejón-Sandoval OC, López-González ÁJ, Castejón-Morett OC

Language: Spanish
References: 27
Page: 335-344
PDF size: 394.84 Kb.


ABSTRACT

Background: HIV patients with normal placental villi can suffer degenerative changes, the hormones that maintain pregnancy (HCG and progesterone) are diminishing, the pH of blood and oxygen tensions lower.
Objective: To demonstrate ultrastructural degenerative changes in placental villi at term of pregnant women infected by HIV-1 with zidovudine treatment.
Material and method: Four placentas at term from seropositive mothers were analyzed; three specimens of each one were processed with conventional transmission electron microscopy. The results were compared with four control cases.
Results: Particles belonging to the viral structure associated with the microvilli of the syncytium and cytoplasmic regions were found. Were observed: interruptions of syncytial plasma membrane, syncytial edema; loss of ribosomes at level of RER, disappearance of mitochondria, Golgi complex, RER, lysosomes and cytoplasmic filaments, dissolution of hyaloplasmic matrix, filopodiums of syncytial membrane, aggregated nuclear heterochromatin and dilated perinuclear cistern. Macrophagues had numerous particles into cytoplasm, probably pertaining to electron dense material contained in the viral nucleocapsid, also observed in the stromal region close to the endothelium of the villus. Some myofibroblasts were detected suffering a process of cellular death with cariorexis event.
Conclusions: These changes indicate that the cytopathic effect spreads from peripheral syncytium to stromal zone suggesting that the damaged placental barrier don’t have the better conditions for the transmission of gases, nutrients and metabolites toward fetal circulation.


REFERENCES

  1. Melero MJ. Síndromes de inmunodeficiencia. En: Argente HA, Álvarez ME, editores. 1a ed. Semiología Médica. Fisiopatología, semiotecnia y propedéutica. Enseñanza basada en el paciente. Buenos Aires: Médica Panamericana, 2006;p:1145-1152.

  2. Benirschke K, Kaufmann P. Pathology of the human placenta. 2nd ed. New York: Springer-Verlag, 2000.

  3. Miller RK, Ebbesen P, Popek EJ, Polliotti B, et al. The role of the placenta in the vertical transmission of HIV and other infectious agents. A Workshop Report. Trophoblast Research 1998;12:225-235.

  4. Ebbensen P, Toth F, Aboagye MG, Zachar B, et al. Vertical transmission of HIV: possible mechanisms and placental responses. Trophoblast Research 1994;8:1-17.

  5. Villegas CH, Carrillo FJ, Paredes Y, Banon A, Karchmer KS. Estudio ultraestructural de placentas en mujeres seropositivas para el VIH. Ginecol Obstet Mex 1994;62:136-142.

  6. Anderson VM, Zevallos E, Gu J. The HIV exposed placenta. Morphologic observations and interpretation. A review. Trophoblast Research 1994;8:47-65.

  7. Castejón SOC, López GAJ, Pérez YLM, Castejón MOC. Presencia de alteraciones histopatológicas en vellosidades placentarias normales en Maracay (Venezuela). Rev Colomb Obstet Ginecol 2009;60:237-246.

  8. Castejón SOC, López GAJ, Pérez YLM, Castejón MOC y col. Alteraciones morfológicas en el espacio intervelloso y en los vasos de vellosidades troncales de embarazadas infectadas con VIH-1 tratadas con zidovudina. Rev Elect Portales Medicos. com 2009;4:442.

  9. D’costa GF, Khadke K, Patil YV. Pathology of placenta in HIV infection. Indian J Pathol Microbiol 2007;50:515-519.

  10. Jauniaux E, Nessmann C, Imbert MC, Meuris S, et al. Morphological aspects of the placentas of HIV pregnancies. Placenta 1988;9:633-642.

  11. Loga EM, Driscoll SG, Munro HN. Comparison of placentae from two socioeconomic groups. I. Morphometry. Pediatrics 1972;50:24-31.

  12. Bulterys M. HIV during pregnancy. Preventing vertical HIV transmission in the year 2000: Progress and Prospects. A review. Trophoblast Research 2001;15:S5-S12.

  13. Connor EM, Sperling RS, Gelber R, Kiselev P, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994;331:1173-1180.

  14. Glauert AM. Fixation, dehydration and embedding of biological specimens. Amsterdam: North-Holland Publishing Company, 1987.

  15. Vidricaire G, Tremblay MJ. A clathrin, caveolae and dynaminindependent endocytic pathway requiring free membrane cholesterol drives HIV-1 internalization and infection in polarized trophoblastic cells. J Mol Biol 2007;368:1267-1283.

  16. Tscherning-Casper C, Papadogiannakis N, Anvret M, Stolpe L, et al. The trophoblastic epithelial barrier is not infected in full-term placentae of human immunodeficiency virus serepositive mothers undergoing antiretroviral therapy. J Virol 1999;73:9673-9678.

  17. Pretorius E, Oberholzer HM, Smit E, Esteyn E, et al. Ultrastructural changes in platelet aggregates of HIV patients: a scanning electron microscopy study. Ultrastruct Pathol 2008; 32:75-79.

  18. Castejón OC, Ali SK, Canache CL. El edema de la vellosidad placentaria en los casos de muerte fetal. Gac Med Caracas 2006;114:291-299.

  19. Bachmaier N, Linnemann K, May K, Warzok R, et al. Ultrastructure of human placental tissue after 6h of normoxic and hypoxic dual in vitro placental perfusion. Placenta 2007;28:861-867.

  20. Vidricaire G, Imbeault M, Tremblay MJ. Endocytic host cell machinery plays a dominant role in intracellular trafficking of incoming human immunodeficiency virus type 1 in human placental trophoblasts. J Virol 2004;78:11904-11915.

  21. Maury W, Pott BS, Pabson AB. HIV-1 infection of first trimester and term human placental tissue. A possible mode of maternal fetus transmission. J Infect Dis 1989;160:583-588.

  22. Villegas CH, Paredes VY, Flores RE, Arredondo GJL, Gorbea RM. Estudio comparativo de la placenta de madres seropositivas a VIH. Análisis ultraestructural. Ginecol Obstet Mex 1996;64:167-176.

  23. Ruga E, Bova S, Nussdorfer G, Mazzocchi G, et al. Zidovudine induced alterations in the heart and vascular smooth muscle of the rat. Cardiovascular Res 2003;15:147-155.

  24. Collier AC, Hellinwell RJ, Keelan JA, Paxton JW, et al. 3’- azido- 3’ deoxythymidine (AZT) induces apoptosis and alters metabolic enzyme activity in human placenta. Toxicol Appl Pharmacol 2003;192:164-173.

  25. Blanche S, Tardien M, Rustin P, Slama A, et al. Persistent mitochondrial dysfunction and perinatal exposure to antirretroviral nucleoside analogues. Lancet 1999;354:1084-1089.

  26. Gichangi PB, Nyongo AO, Temmerman M. Pregnancy outcome and placental weights: Their relationship to HIV-1 infection. East Afr Med J 1993;70:85-89.

  27. Bryson YJ, Mirochnick M, Stek A, Mofenson LM, et al. Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353. HIV Clin Trials 2008;9:115-125.




2020     |     www.medigraphic.com